Purchase disclosed
Erez Chimovits
Director
Common Stock
- Reported value
- $1.05M
- Reported price
- $17.00 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
ADARx Pharmaceuticals, Inc.
Last 30 daysInsiders bought $87.75M · 5 buyers, led by Sr One Capital Management (10% owner) with $27.2M. No qualifying insider sales.
Showing the first 6 of 13 trades on this page.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
10% owner
Common Stock
10% owner
Common Stock
10% owner
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockPurchase | 61,516$17.00 / share | $1.05M | Sep 28Filed Sep 30 · 2d later | SEC filing |
| Director | Common StockPurchase3 trades | 950,000avg $17.00 / share | $16.15M | Sep 28Filed Sep 30 · 2d later | 3 filings
|
| +4Director | Common StockPurchase3 trades | 950,000avg $17.00 / share | $16.15M | Sep 28Filed Sep 30 · 2d later | 3 filings
|
| 10% owner | Common StockPurchase3 trades | 1,600,000avg $17.00 / share | $27.2M | Sep 28Filed Sep 29 · 1d later | 3 filings
|
| Director | Common StockPurchase3 trades | 1,600,000avg $17.00 / share | $27.2M | Sep 28Filed Sep 29 · 1d later | 3 filings
|
$87,745,772 of common-equity purchase value after transaction-age decay across 180 days.
5 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
5 buying groups inside 30 transaction-date days, public by the snapshot cutoff.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
This reflects the filings imported so far, not a complete trading history.